½ÃÀ庸°í¼­
»óǰÄÚµå
1553629

ô¼ö°­³» ÆßÇÁ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : À¯Çüº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)

Intrathecal Pumps Market Size, Share & Trends Analysis Report By Type (Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide), By Application (Pain, Spasticity), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ô¼ö°­³» ÆßÇÁ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ Ã´¼ö°­³» ÆßÇÁ ½ÃÀå ±Ô¸ð´Â 2030³â¿¡ 5¾ï 1,330¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2030³â CAGR 5.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸´Ù ºü¸¥ ÅëÁõ ¿ÏÈ­¸¦ À§ÇØ Ã´¼ö¿¡ ¾à¹°À» ½Å¼ÓÇÏ°Ô Àü´ÞÇϱâ À§ÇÑ Ã·´Ü ô¼ö°­³» ÆßÇÁ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ô¼ö°­³» ÆßÇÁ¿Í °ü·ÃµÈ ÀÌÁ¡Àº »ê¾÷ ¼ºÀåÀ» °­È­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ô¼ö°­³» Åõ¿© ÆßÇÁ¸¦ ÅëÇØ ¿ÀÇÇ¿ÀÀ̵å¿Í °°Àº ¾à¹°À» Åõ¿©Çϸé ÁøÅë È¿°ú°¡ ¶Ù¾î³¯ »Ó¸¸ ¾Æ´Ï¶ó ºÎÀÛ¿ëÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÅëÁõ ÆßÇÁ´Â Á¤Á¦·Î º¹¿ëÇÏ´Â ¾à¹°ÀÇ ¾ç¿¡ ºñÇØ ¼Ò·®¸¸ º¹¿ëÇÏ¸é µÇ¹Ç·Î °³ÀÎµé »çÀÌ¿¡¼­ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¾à¹°Àü´Þ ½Ã½ºÅÛÀº È¿°úÀûÀÎ ÅëÁõ ¿ÏÈ­, ³ôÀº ȯÀÚ ¸¸Á·µµ, °æ±¸¿ë ¾à¹°¿¡ ºñÇØ ºÎÀÛ¿ë °¨¼Ò, ÁøÅëÁ¦ »ç¿ë·® °¨¼Ò µî ¸¹Àº ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÀÌ Ä¡·á¹ýÀº Áö½Ã´ë·Î »ç¿ëÇϸé È¿°úÀûÀÌ°í ¾ÈÀüÇϸç, Çʿ信 µû¶ó ¿ë·®À» Á¶ÀýÇÏ¿© ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ Ç¥Àû ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹æ±¤³» Ä«Å×ÅÍ¿Í °ü·ÃµÈ ÇÕº´ÁõÀº »ê¾÷ ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. Ä«Å×ÅͰ¡ ¸·È÷°Å³ª Âõ¾îÁö°Å³ª Àý´ÜµÇ¸é ô¼ö°­³» Ä«Å×ÅÍ °íÀåÀ¸·Î ÀÎÇØ ô¼ö°­³» ¾à¹° Åõ¿©°¡ °©ÀÚ±â Áß´ÜµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾à¹°Àü´Þ Àåºñ¿Í °ü·ÃµÈ ºÎÀÛ¿ëÀÇ ´ëºÎºÐÀº ¹æ±¤³» Ä«Å×ÅÍ °íÀåÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù.

ô¼ö°­³» ÆßÇÁ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¸ôÇÉ À¯ÇüÀº ´ë·® °æ±¸¿ë ¿ÀÇÇ¿ÀÀ̵忡 ºñÇØ Àú¿ë·®À¸·Î ÁøÅë È¿°ú¸¦ ¾òÀ» ¼ö ÀÖ°í ü°èÀû ºÎÀÛ¿ëÀÌ Àû¾î 2023³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ÅëÁõ ¿ëµµ´Â ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÀÌ´Â ÅëÁõ °ü·Ã ÁúȯÀÇ Ä¡·á È¿À²À» ³ôÀΠ÷´Ü ô¼ö°­³» ÆßÇÁ°¡ °³¹ßµÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù.
  • ºÏ¹Ì´Â 2023³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ Áß¿¡µµ Áö¹èÀûÀÎ À§Ä¡¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÀÌ´Â ¸¸¼º ¿äÅëÀÇ ³ôÀº À¯º´·ü°ú ¹Ì±¹, ij³ª´Ù µîÀÇ ±¹°¡¿¡¼­ ¿¬±¸°³¹ß ºñ¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ô¼ö°­³» ÆßÇÁ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ô¼ö°­³» ÆßÇÁ ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ô¼ö°­³» ÆßÇÁ ½ÃÀå : À¯Çüº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ô¼ö°­³» ÆßÇÁ ½ÃÀå : À¯Çüº° º¯µ¿ ºÐ¼®
  • ô¼ö°­³» ÆßÇÁ ½ÃÀå : À¯Çüº° Àü¸Á
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • Baclofen
  • Bupivacaine
  • Clonidine
  • Morphine
  • Ziconotide
  • ±âŸ

Á¦5Àå ô¼ö°­³» ÆßÇÁ ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ô¼ö°­³» ÆßÇÁ ½ÃÀå : ¿ëµµº° º¯µ¿ ºÐ¼®
  • ¿ëµµº° ô¼ö°­³» ÆßÇÁ ½ÃÀå Àü¸Á
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • °æÁ÷
  • ÅëÁõ

Á¦6Àå ô¼ö°­³» ÆßÇÁ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ´ë½Ãº¸µå
  • Áö¿ªº° ô¼ö°­³» ÆßÇÁ ½ÃÀ庯¼ö ºÐ¼®
  • ô¼ö°­³» ÆßÇÁ ½ÃÀå : À¯Çü°ú ¿ëµµº° Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ½ÃÀå Âü¿© ±â¾÷ÀÇ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Medtronic plc
    • Tricumed GmbH
    • Arrow International
    • Codman &Shurtleff
    • Medallion Therapeutics
    • Flowonix
    • Smith's Medical
    • Teleflex Incorporated
KSA 24.09.25

Intrathecal Pumps Market Growth & Trends:

The global intrathecal pumps market size is expected to reach at USD 513.3 million in 2030 and is projected to grow at a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for advanced intrathecal pumps for rapid delivery of medications into the spinal cord for faster pain relief is expected to boost the industry's growth during the forecast period.The advantages associated with intrathecal pumps are anticipated to augment the industry growth. Medications, such as opioids, when given through an intrathecal pain pump give superior pain relief as well as reduce side effects. Also, a small amount of medication is required in pain pumps as compared to the amount of medication taken in pill form, thereby increasing its preference among individuals.

The drug delivery therapy systems offer numerous benefits, such as effective pain relief, high patient satisfaction, reduced side effects compared to oral medication, and reduced use of pain medication. In addition, this treatment is effective and safe when used as directed and can be customized by varying the dosage as per need. Hence, rising demand for targeted drug delivery systems is expected to boost industry growth.The complications associated with the intrathecal catheter are creating hindrance in the industry growth. Occlusion, lacerations, and disconnection of the catheter cause a sudden cessation of intrathecal drug administration due to intrathecal catheter failure. Also, the majority of drug delivery device-related adverse events occurdue to the failure of the intrathecal catheter.

Intrathecal Pumps Market Report Highlights:

  • The morphine type segment held the largest revenue share in 2023 as intrathecal morphine receives analgesic effect at a lower dose with less systematic side effects as compared to large dose oral opioids.
  • The pain application segment is expected to grow at the fastest CAGR during the forecast period
  • This is owing to the development of advanced intrathecal pumps having enhanced efficiency in treating pain-related disorders
  • North America accounted for the largest revenue share in 2023 and is projected to maintain its dominant position throughout the forecast years
  • This is attributed to the high prevalence of chronic back pain and increased R&D expenditure in countries, such as the U.S. and Canada

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Intrathecal Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic back pain and muscle spasticity
      • 3.2.1.2. Increasing demand for targeted drug delivery systems
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Technological and surgical complications
  • 3.3. Intrathecal Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Intrathecal Pumps Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Intrathecal Pumps Market: Type Movement Analysis
  • 4.3. Intrathecal Pumps Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Baclofen
    • 4.5.1. Baclofen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Bupivacaine
    • 4.6.1. Bupivacaine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Clonidine
    • 4.7.1. Clonidine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Morphine
    • 4.8.1. Morphine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Ziconotide
    • 4.9.1. Ziconotide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Intrathecal Pumps Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Intrathecal Pumps Market: Application Movement Analysis
  • 5.3. Intrathecal Pumps Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Spasticity
    • 5.5.1. Spasticity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Pain
    • 5.6.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Intrathecal Pumps Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional Intrathecal Pumps Market movement analysis
  • 6.3. Intrathecal Pumps Market: Regional Estimates & Trend Analysis by Type & Application
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. U.S. Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Canada Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. Mexico Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. UK Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Germany Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. France Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Italy Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Spain Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Denmark Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Sweden Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Reimbursement scenario
      • 6.6.9.5. Norway Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Japan
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Japan Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. China
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. China Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. India
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. India Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Australia
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Australia Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Thailand Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Latin America Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Brazil Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Argentina Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Middle East & Africa
    • 6.9.1. Middle East & Africa Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. South Africa Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Saudi Arabia Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.4. UAE
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. UAE Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Reimbursement scenario
      • 6.9.5.5. Kuwait Intrathecal Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Medtronic plc
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Type benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Tricumed GmbH
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Type benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Arrow International
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Type benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Codman & Shurtleff
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Type benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Medallion Therapeutics
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Type benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Flowonix
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Type benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Smith's Medical
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Type benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Teleflex Incorporated
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Type benchmarking
      • 7.2.8.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦